PATENT CLAIM ANALYSIS

Application Number: 15775328
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2019-07
Patent Classification: ["424", "133100"]

Abstract:
The composition of anti-TNFR2 antibodies are provided, as well as methods of their preparation and use. This includes methods for treating disorders associated with TNF and/or TNFR2, such as cancer.

Claim (Index 119):
The humanized anti-TNFR2 antibody of  claim 117 , wherein said anti-TNFR2 antibody comprises a set of three heavy chain complementary determining regions (HCDRs) and three light chain complementary determining regions (LCDRs), wherein the set of three HCDRs and three LCDRs are selected from the group consisting of:\n a) SEQ ID NOs: 10-12 (HCDRs) and SEQ ID NOs: 13-15 (LCDRs); and b) SEQ ID NOs: 16-18 (HCDRs) and SEQ ID NOs: 19-21 (LCDRs).

Metadata:
- Claim Count in Document: 35.0
- Percentile: 93.0
- Lexical Diversity: 1.21429
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15849771', '14662349', '14031075', '15223434', '15820054']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7903305542032674
- 35 USC 102 Novelty (BERT): 0.5345054536275979
- Combined Prediction Score: 0.7647480441457005
- Mean Citation Score: 361.482638
- Max Citation Score: 378.9163
- Similarity Product: 291.5263893921435

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test